droxidopa has been researched along with Attention Deficit Disorder with Hyperactivity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dela Peña, I; Shen, G; Shi, WX | 1 |
Adler, LA; Gorny, SW | 1 |
Buoli, M; Cahn, W; Serati, M | 1 |
1 review(s) available for droxidopa and Attention Deficit Disorder with Hyperactivity
Article | Year |
---|---|
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2016 |
2 other study(ies) available for droxidopa and Attention Deficit Disorder with Hyperactivity
Article | Year |
---|---|
Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Benserazide; Delay Discounting; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Droxidopa; Drug Therapy, Combination; Locomotion; Male; Maze Learning; Prefrontal Cortex; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Species Specificity; Ventral Tegmental Area | 2021 |
Pilot Study of Droxidopa With Carbidopa in Adults With ADHD.
Topics: Adult; Antiparkinson Agents; Attention Deficit Disorder with Hyperactivity; Carbidopa; Double-Blind Method; Droxidopa; Female; Humans; Male; Middle Aged; Pilot Projects; Treatment Outcome | 2019 |